Skip to main content
Erschienen in: Internal and Emergency Medicine 3/2021

19.08.2020 | IM - ORIGINAL

Modes of death in heart failure according to age, sex and left ventricular ejection fraction

verfasst von: Prado Salamanca-Bautista, Jesús Álvarez-García, Óscar Aramburu-Bodas, Andreu Ferrero-Gregori, José Luis Arias-Jiménez, Juan F. Delgado, Francesc Formiga, Rafael Vázquez, Luis Manzano, Teresa Puig, Pau Llàcer, Miquel Vives-Borras, Juan Cinca, Manuel Montero-Pérez-Barquero, the REDINSCOR, RICA Investigators groups

Erschienen in: Internal and Emergency Medicine | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Modes of death in patients with heart failure (HF) have been well characterized in randomized studies, but data from real-life are scarce, especially in the elderly, women and in HF with mid-range or preserved left ventricular ejection fraction (LVEF). Our purpose was to examine modes of death in HF patients according to age, sex and LVEF. We analysed the mode of death of HF patients from two prospective multicentre contemporary Spanish registries conducted by cardiologists (REDINSCOR, n = 2150) and by internists (RICA, n = 1396). Mode of death was pre-specified. Out of 3546 patients, 485 (13.7%) died during the 9-month follow-up. Cardiovascular (CV) causes were the most frequent, regardless of the age, sex and LVEF. More than half of patients died due to worsening HF in both groups of patients, followed by other non-CV causes in those attended by internists, and sudden cardiac death in those cared by cardiologists. Stroke was more common among elderly patients, women and HF with preserved LVEF. Non-CV causes, particularly infectious diseases, accounted for a remarkable proportion of deaths, especially in the elderly and in HF patients with preserved LVEF. Functional class, age and anaemia had a strong influence on both CV and non-CV death. CV death due to refractory HF was the most prevalent among our population, irrespective of age, sex or LVEF. However, a significant proportion of HF patients died from non-CV causes, particularly elderly with mid-range and preserved LVEF. These patients could benefit significantly from a multidisciplinary follow-up.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Farré N, Vela E, Clèries M, Bustins M, Cainzos-Achirica M, Enjuanes C et al (2017) Real world heart failure epidemiology and outcome: a population-based analysis of 88,195 patients. PLoS ONE 12:e0172745CrossRef Farré N, Vela E, Clèries M, Bustins M, Cainzos-Achirica M, Enjuanes C et al (2017) Real world heart failure epidemiology and outcome: a population-based analysis of 88,195 patients. PLoS ONE 12:e0172745CrossRef
2.
Zurück zum Zitat Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ et al (2004) Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment o reduction in mortality and morbidity (CHARM) program. Circulation 110:2180–2183CrossRef Solomon SD, Wang D, Finn P, Skali H, Zornoff L, McMurray JJ et al (2004) Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment o reduction in mortality and morbidity (CHARM) program. Circulation 110:2180–2183CrossRef
3.
Zurück zum Zitat Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB et al (2010) Mode of death in patients with heart failure and a preserved ejection fraction. Results from the irbesartan in heart failure with preserved ejection fraction study (I-preserve) trial. Circulation 121:1393–1405CrossRef Zile MR, Gaasch WH, Anand IS, Haass M, Little WC, Miller AB et al (2010) Mode of death in patients with heart failure and a preserved ejection fraction. Results from the irbesartan in heart failure with preserved ejection fraction study (I-preserve) trial. Circulation 121:1393–1405CrossRef
4.
Zurück zum Zitat Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21CrossRef Zannad F, McMurray JJV, Krum H, van Veldhuisen DJ, Swedberg K, Shi H et al (2011) Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 364:11–21CrossRef
5.
Zurück zum Zitat Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B et al (2014) Spironolactone form heart failure with preserved ejection fraction. N Engl J Med 370:1383–1392CrossRef Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B et al (2014) Spironolactone form heart failure with preserved ejection fraction. N Engl J Med 370:1383–1392CrossRef
6.
Zurück zum Zitat Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F et al (2015) Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J 36:1990–1997CrossRef Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F et al (2015) Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients. Eur Heart J 36:1990–1997CrossRef
7.
Zurück zum Zitat Rickenbacher P, Pfisterer M, Burkard T, Kiowski W, Follath F, Burckhardt D et al (2012) Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study. Eur J Heart Fail 14:1218–1229CrossRef Rickenbacher P, Pfisterer M, Burkard T, Kiowski W, Follath F, Burckhardt D et al (2012) Why and how do elderly patients with heart failure die? Insights from the TIME-CHF study. Eur J Heart Fail 14:1218–1229CrossRef
8.
Zurück zum Zitat Vaduganathan M, Patel RB, Michel A, Shah SJ, Senni M, Gheorghiade M et al (2017) Mode of death in heart failure with preserved ejection fraction. J Am Coll Cardiol 69:556–569CrossRef Vaduganathan M, Patel RB, Michel A, Shah SJ, Senni M, Gheorghiade M et al (2017) Mode of death in heart failure with preserved ejection fraction. J Am Coll Cardiol 69:556–569CrossRef
9.
Zurück zum Zitat Hamaguchi S, Kinugawa S, Sobirin MA, Goto D, Tsuchihashi-Makaya M, Yamada S et al (2012) Mode of death in patients with heart failure and reduce vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients. Circ J 76:1662–1669CrossRef Hamaguchi S, Kinugawa S, Sobirin MA, Goto D, Tsuchihashi-Makaya M, Yamada S et al (2012) Mode of death in patients with heart failure and reduce vs. preserved ejection fraction: report from the registry of hospitalized heart failure patients. Circ J 76:1662–1669CrossRef
10.
Zurück zum Zitat Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL (2008) Death in heart failure. A community perspective. Circ Heart Fail 1:91–97CrossRef Henkel DM, Redfield MM, Weston SA, Gerber Y, Roger VL (2008) Death in heart failure. A community perspective. Circ Heart Fail 1:91–97CrossRef
11.
Zurück zum Zitat Lee DS, Gona P, Albano I, Larson MG, Benjamin EJ, Levy D et al (2011) A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period and left ventricular systolic dysfunction. Circ Heart Fail 4:36–43CrossRef Lee DS, Gona P, Albano I, Larson MG, Benjamin EJ, Levy D et al (2011) A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period and left ventricular systolic dysfunction. Circ Heart Fail 4:36–43CrossRef
12.
Zurück zum Zitat Moliner P, Lupon J, de Antonio M, Domingo M, Santiago-Vacas E, Zamora E et al (2019) Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise. Eur J Heart Fail 21:1259–1266CrossRef Moliner P, Lupon J, de Antonio M, Domingo M, Santiago-Vacas E, Zamora E et al (2019) Trends in modes of death in heart failure over the last two decades: less sudden death but cancer deaths on the rise. Eur J Heart Fail 21:1259–1266CrossRef
13.
Zurück zum Zitat Wakabayashi K, Ikeda N, Kajimoto K, Minami Y, Keida T, Asai K et al (2018) Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure. Int J Cardiol 250:164–170CrossRef Wakabayashi K, Ikeda N, Kajimoto K, Minami Y, Keida T, Asai K et al (2018) Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure. Int J Cardiol 250:164–170CrossRef
14.
Zurück zum Zitat Álvarez-García J, Salamanca-Bautista P, Ferrero-Gregori A, Montero-Pérez-Barquero M, Puig T, Aramburu-Bodas O et al (2017) Prognostic impact of physician specialty on the prognosis of outpatients with Heart Failure: propensity matched analysis of the REDINSCOR and RICA Registries. Rev Esp Cardiol (Engl Ed) 70:347–354CrossRef Álvarez-García J, Salamanca-Bautista P, Ferrero-Gregori A, Montero-Pérez-Barquero M, Puig T, Aramburu-Bodas O et al (2017) Prognostic impact of physician specialty on the prognosis of outpatients with Heart Failure: propensity matched analysis of the REDINSCOR and RICA Registries. Rev Esp Cardiol (Engl Ed) 70:347–354CrossRef
17.
Zurück zum Zitat Haukoos JS, Newgard CD (2007) Advanced statistics: missing data in clinical research-part 1: an introduction and conceptual framework. Acad Emerg Med 14:662–668PubMed Haukoos JS, Newgard CD (2007) Advanced statistics: missing data in clinical research-part 1: an introduction and conceptual framework. Acad Emerg Med 14:662–668PubMed
18.
Zurück zum Zitat Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF et al (2017) Declining risk of sudden death in heart failure. N Engl J Med 377:41–51CrossRef Shen L, Jhund PS, Petrie MC, Claggett BL, Barlera S, Cleland JGF et al (2017) Declining risk of sudden death in heart failure. N Engl J Med 377:41–51CrossRef
19.
Zurück zum Zitat Cubbon RM, Gale CP, Kearny LC, Schechter CB, Brooksby P, Nolan J et al (2011) Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction. A study across therapeutic eras. Circ Heart Fail. 4:396–403CrossRef Cubbon RM, Gale CP, Kearny LC, Schechter CB, Brooksby P, Nolan J et al (2011) Changing characteristics and mode of death associated with chronic heart failure caused by left ventricular systolic dysfunction. A study across therapeutic eras. Circ Heart Fail. 4:396–403CrossRef
20.
Zurück zum Zitat Fernandez-Vazquez D, Ferrero-Gregori A, Alvarez-Garcia J, Gomez-Otero I, Vazquez R, Delgado-Jimenez J et al. Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol (Engl Ed). https://doi.org/10.1016/j.recesp.2019.09.012 Fernandez-Vazquez D, Ferrero-Gregori A, Alvarez-Garcia J, Gomez-Otero I, Vazquez R, Delgado-Jimenez J et al. Changes in causes of death and influence of therapeutic improvement over time in patients with heart failure and reduced ejection fraction. Rev Esp Cardiol (Engl Ed). https://​doi.​org/​10.​1016/​j.​recesp.​2019.​09.​012
21.
Zurück zum Zitat Grigorian-Shamagian L, Otero Ravin F, Abu Assi E, Vidal Pérez R, Teijeira-Fernandez E, Varela Roman A et al (2008) Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. Am Heart J 156:1184–1190CrossRef Grigorian-Shamagian L, Otero Ravin F, Abu Assi E, Vidal Pérez R, Teijeira-Fernandez E, Varela Roman A et al (2008) Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. Am Heart J 156:1184–1190CrossRef
22.
Zurück zum Zitat Pons F, Lupón J, Urrutia A, González B, Crespo E, Díez C et al (2010) Mortality and cause of death in patients with heart failure: findings at a specialist multidisciplinary heart failure unit. Rev Esp Cardiol 63:303–314CrossRef Pons F, Lupón J, Urrutia A, González B, Crespo E, Díez C et al (2010) Mortality and cause of death in patients with heart failure: findings at a specialist multidisciplinary heart failure unit. Rev Esp Cardiol 63:303–314CrossRef
23.
Zurück zum Zitat Martens P, Verbrugge FH, Nijst P, Dupont M, Mullens W (2016) Mode of death in octogenarians treated with cardiac resynchronization therapy. J Card Fail 22:970–977CrossRef Martens P, Verbrugge FH, Nijst P, Dupont M, Mullens W (2016) Mode of death in octogenarians treated with cardiac resynchronization therapy. J Card Fail 22:970–977CrossRef
24.
Zurück zum Zitat Aschauer S, Zotter-Tufaro C, Duca F, Kammerlander A, Dalos D, Mascherbauer J et al (2017) Modes of death in patients with heart failure and preserved ejection fraction. Int J Cardiol 228:422–426CrossRef Aschauer S, Zotter-Tufaro C, Duca F, Kammerlander A, Dalos D, Mascherbauer J et al (2017) Modes of death in patients with heart failure and preserved ejection fraction. Int J Cardiol 228:422–426CrossRef
25.
Zurück zum Zitat Walker AMN, Drozd M, Hall M, Patel PA, Paton M, Lowry J et al (2018) Prevalence and predictors of sepsis death in patients with chronic heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc 7:e009684CrossRef Walker AMN, Drozd M, Hall M, Patel PA, Paton M, Lowry J et al (2018) Prevalence and predictors of sepsis death in patients with chronic heart failure and reduced left ventricular ejection fraction. J Am Heart Assoc 7:e009684CrossRef
26.
Zurück zum Zitat Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A et al (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310:1711–1720CrossRef Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A et al (2013) Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 310:1711–1720CrossRef
27.
Zurück zum Zitat Modin D, JØrgensen ME, Gislason G, Jensen JS, KØber L, Claggett B et al (2019) Influenza vaccine in heart failure. Circulation 139:575–586CrossRef Modin D, JØrgensen ME, Gislason G, Jensen JS, KØber L, Claggett B et al (2019) Influenza vaccine in heart failure. Circulation 139:575–586CrossRef
28.
Zurück zum Zitat Adabag S, Smith LG, Anand IS, Berger AK, Luepker RV (2012) Sudden cardiac death in heart failure patients with preserved ejection fraction. J Card Fail 18:749–754CrossRef Adabag S, Smith LG, Anand IS, Berger AK, Luepker RV (2012) Sudden cardiac death in heart failure patients with preserved ejection fraction. J Card Fail 18:749–754CrossRef
29.
Zurück zum Zitat Chan MMY, Lam CSP (2013) How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 15:604–613CrossRef Chan MMY, Lam CSP (2013) How do patients with heart failure with preserved ejection fraction die? Eur J Heart Fail 15:604–613CrossRef
30.
Zurück zum Zitat Sato Y, Yoshihisa A, Kimishima Y, Yokokawa T, Abe S, Shimizu T et al (2020) Prognostic factors in heart failure with cardiac cachexia. J Geriatr Cardiol 17:26–34PubMedPubMedCentral Sato Y, Yoshihisa A, Kimishima Y, Yokokawa T, Abe S, Shimizu T et al (2020) Prognostic factors in heart failure with cardiac cachexia. J Geriatr Cardiol 17:26–34PubMedPubMedCentral
31.
Zurück zum Zitat Narang R, Cleland JGF, Erhardt L, Ball SG, Coats AJS, Cowley AJ et al (1996) Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 17:1390–1403CrossRef Narang R, Cleland JGF, Erhardt L, Ball SG, Coats AJS, Cowley AJ et al (1996) Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 17:1390–1403CrossRef
Metadaten
Titel
Modes of death in heart failure according to age, sex and left ventricular ejection fraction
verfasst von
Prado Salamanca-Bautista
Jesús Álvarez-García
Óscar Aramburu-Bodas
Andreu Ferrero-Gregori
José Luis Arias-Jiménez
Juan F. Delgado
Francesc Formiga
Rafael Vázquez
Luis Manzano
Teresa Puig
Pau Llàcer
Miquel Vives-Borras
Juan Cinca
Manuel Montero-Pérez-Barquero
the REDINSCOR, RICA Investigators groups
Publikationsdatum
19.08.2020
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 3/2021
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-020-02468-z

Weitere Artikel der Ausgabe 3/2021

Internal and Emergency Medicine 3/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

RAS-Blocker bei Hyperkaliämie möglichst nicht sofort absetzen

14.05.2024 Hyperkaliämie Nachrichten

Bei ausgeprägter Nierenfunktionsstörung steigen unter der Einnahme von Renin-Angiotensin-System(RAS)-Hemmstoffen nicht selten die Serumkaliumspiegel. Was in diesem Fall zu tun ist, erklärte Prof. Jürgen Floege beim diesjährigen Allgemeinmedizin-Update-Seminar.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.